PPARG and metabolic dysfunction-associated steatohepatitis: Therefore, it is possible that the anti-NASH effects of TZD, which are based mainly on their insulin-sensitizing effects, may be offset in somehow by the activation of hepatocyte-specific PPARγ by endogenous ligands and/or TZD.